Table 4.
Rhamnolipid congener pattern observed upon expression of the RhlAPa-A182P/RhlBPa variant with respect to RhlAPa-WT/RhlBPa in a BGR1ΔrhlA background.
| Variant | C8 (%)* | C10 (%)* | C12 (%)* |
|---|---|---|---|
| RhlAPa-WT | 5.4 (± 0.6) | 74.3 (± 0.6) | 20.3 (± 0.6) |
| RhlAPa-A182P | 7.9 (± 0.6) | 65.1 (± 1.1) | 27.0 (± 1.3) |
Fatty acid contribution were calculated from LC/MS negative mode analysis of congeners C8-C8 (m/z 301.3), Rha-C8-C8 (m/z 447.3), Rha-Rha-C8-C8 (m/z 593.5), C8-C10/C10-C8 (m/z 329.3), Rha-C8-C10/Rha-C10-C8 (m/z 475.4), Rha-Rha-C8-C10/Rha-Rha-C10-C8 (m/z 621.6), C10-C10 (m/z 357.3), Rha-C10-C10 (m/z 503.4), Rha-Rha-C10-C10 (m/z 649.5), C10-C12/C12-C10 (m/z 385.3), Rha-C10-C12/Rha-C12-C10 (m/z 531.4), Rha-Rha-C10-C12/Rha-Rha-C12-C10 (m/z 677.5), C12-C12 (m/z 413.6), Rha-C12-C12 (m/z 559.7), and Rha-Rha-C12-C12 (m/z 705.5). No others congeners longer than C12 were detected.